2020
DOI: 10.21203/rs.3.rs-41474/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

From Pan-genome to the Genomic Context of the Two Integrons of ST-111 Pseudomonas Aeruginosa AG1: A VIM-2-carrying Old-acquaintance and a Novel Imp-18-carrying Integron

Abstract: Background Pseudomonas aeruginosa is an opportunist and versatile organism responsible for infections among immunocompromised hosts. This pathogen has high intrinsic resistance to most antimicrobials, including critical strains due to resistance to carbapenems, a last-resort antibiotic. P. aeruginosa AG1 (PaeAG1) is a Costa Rican high-risk ST-111 strain with resistance to multiple antibiotics, including carbapenems due to the activity of both VIM-2 and IMP-18 metallo-β-lactamases (MBLs). These genes are harb… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…We reported this isolated in 2015 [58] and it is a Priority 1 organism [59] because it is resistant to carbapenems, a last-resort antibiotic. We assembled the genome using Illumina and Nanopore sequencing [13], revealing the genomic features including two integrons, which were studied in detail in another work [60]. Proteomic profiles after exposure to antibiotics have been also studied [61].…”
Section: Discussionmentioning
confidence: 99%
“…We reported this isolated in 2015 [58] and it is a Priority 1 organism [59] because it is resistant to carbapenems, a last-resort antibiotic. We assembled the genome using Illumina and Nanopore sequencing [13], revealing the genomic features including two integrons, which were studied in detail in another work [60]. Proteomic profiles after exposure to antibiotics have been also studied [61].…”
Section: Discussionmentioning
confidence: 99%